Release Date: 06/04/16 09:41 Summary: Eighth Supplementary Bidder's Statement - Variation-BRS.AX Price Sensitive: No Download Document 346.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%